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PSuppression of Re-Entrant and
Multifocal Ventricular Fibrillation by the
Late Sodium Current Blocker Ranolazine
Norishige Morita, MD,* Jong Hwan Lee, MD, PHD,*† Yuanfang Xie, PHD,* Ali Sovari, MD,*
Zhilin Qu, PHD,* James N. Weiss, MD,* Hrayr S. Karagueuzian, PHD*
Los Angeles, California; and Seoul, South Korea
Objectives The purpose of this study was to test the hypothesis that the late Na current blocker ranolazine suppresses re-
entrant and multifocal ventricular fibrillation (VF).
Background VF can be caused by either re-entrant or focal mechanism.
Methods Simultaneous voltage and intracellular Ca2 optical mapping of the left ventricular epicardial surface along with
microelectrode recordings was performed in 24 isolated-perfused aged rat hearts. Re-entrant VF was induced by
rapid pacing and multifocal VF by exposure to oxidative stress with 0.1 mM hydrogen peroxide (H2O2).
Results Rapid pacing induced sustained VF in 7 of 8 aged rat hearts, characterized by 2 to 4 broad propagating wave-
fronts. Ranolazine significantly (p  0.05) reduced the maximum slope of action potential duration restitution
curve and converted sustained to nonsustained VF lasting 24  8 s in all 7 hearts. Exposure to H2O2 initiated
early afterdepolarization (EAD)-mediated triggered activity that led to sustained VF in 8 out of 8 aged hearts. VF
was characterized by multiple foci, appearing at an average of 6.8  3.2 every 100 ms, which remained con-
fined to a small area averaging 2.8  0.85 mm2 and became extinct after a mean of 43  16 ms. Ranolazine
prevented (when given before H2O2) and suppressed H2O2-mediated EADs by reducing the number of foci, caus-
ing VF to terminate in 8 out of 8 hearts. Simulations in 2-dimensional tissue with EAD-mediated multifocal VF
showed progressive reduction in the number of foci and VF termination by blocking the late Na current.
Conclusions Late Na current blockade with ranolazine is effective at suppressing both pacing-induced re-entrant VF and EAD-
mediated multifocal VF. (J Am Coll Cardiol 2011;57:366–75) © 2011 by the American College of Cardiology
Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2010.07.045(
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rharmacologic and genetic approaches to treatment of
entricular fibrillation (VF) must take into account its
echanistic complexity. VF can be caused by both re-
ntrant and focal mechanisms, as well as mixtures of the 2.
apid pacing-induced VF generally is attributed to re-
ntrant mechanisms, resulting from either multiple wavelets
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ccepted July 17, 2010.1) or a mother rotor (2), depending on experimental
onditions (3). However, drugs and genetic defects that
educe repolarization reserve (prolong repolarization) and
lter intracellular Ca2 (Cai
2) cycling promote polymor-
hic ventricular arrhythmias degenerating to VF, in which
ocal mechanisms are involved in VF initiation and main-
enance. For example, local application of aconitine, which
mpairs Na current inactivation, induces a form of VF that
s maintained by focal activity originating from the site of
conitine application (4,5). Multifocal VF also can be
nduced by oxidative stress with hydrogen peroxide (H2O2),
hich is driven by early afterdepolarization (EAD)-
ediated triggered activity generating multiple short-lived
oci continuously shifting in location (6,7).
Ranolazine, which preferentially blocks the late Na current
INa-L) (8,9), is a clinically useful antianginal drug that has been
hown to exert antiarrhythmic actions as well (10). In this
espect, ranolazine is shown to reduce the dispersion of
entricular action potential duration (APD) (11–13), an effect
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January 18, 2011:366–75 Late Sodium Current and Fibrillationhat may account for the drug’s demonstrated efficacy to
ncrease VF threshold and decrease ventricular defibrillation
hreshold of re-entrant VF. (14) Ranolazine also has been
hown to suppress EADs and triggered activity in isolated
ardiac myocytes exposed to H2O2 (8,15); however, its effects
n the initiation and maintenance of EAD-mediated multifo-
al oxidative VF in intact hearts have not been evaluated.
2O2 has pleiotropic effects, including direct effects on ion
hannel and transporter proteins and indirect effects mediated
y activating Ca-calmodulin kinase II signaling pathways
16–18), which enhance the late Na current, promoting EADs
nd triggered activity (8,15,19). The aim of this study was to
ompare the effects of ranolazine on pacing induced re-entrant
F and on H2O2-induced multifocal VF.
ethods
he research protocol was approved by the Institutional
nimal Care and Use Committee and followed the guide-
ines of American Heart Association.
angendorff setting. We used male Fisher344 rats age 24
o 26 months (n  24) purchased from the National
nstitute on Ageing, Bethesda, Maryland. The hearts of the
nesthetized rats were removed and the ascending aorta was
annulated for retrograde perfusion with warm (36.5 
.50°C) oxygenated Tyrode’s solution, as described previ-
usly (6,20).
ptical mapping. The hearts were stained with RH237
nd Rhod-2 AM (Invitrogen Molecular Probes, Carlsbad,
alifornia) for simultaneous dual voltage and Cai
2 fluo-
escent optical imaging, respectively, as described previously
6). Cai
2 transient decay rate constant, , was determined
y a monoexponential fit during the relaxation before and
fter ranolazine (6). Cytochalasin D (5 M) was added to
he perfusate to inhibit motion (6). Single-cell action
otentials were recorded with glass microelectrodes from
he base of the left ventricle (LV) epicardium, the site of the
ocal activity during the onset of VT as determined by
ptical mapping (6). An epicardial wavefront was consid-
red to be focal when it arose from within the mapped
egion (i.e., did not propagate into the mapped region from
he outside) and was surrounded with nonexcited tissue. We
reviously showed that after extensive endomyocardial and
idmyocardial cryoablation, the epicardial surface cells
enerate focal activity independent of breakthrough excita-
ion from deeper cells (6).
ynamic APD restitution. Epicardial APD was measured
t 90% and 50% repolarization from multiple epicardial cells
3 to 5 cells) recorded with microelectrodes from base mid
nd apical regions in 8 hearts before and after ranolazine.
PD restitution curves were determined using a dynamic
acing protocol, as described previously (6,20).
harmacological interventions. The isolated hearts first
ere perfused with normal Tyrode’s solution, and baseline
acing-induced arrhythmias were recorded and imaged.
hen, the effect of ranolazine (10 M) on inducible VF was avaluated 20 min after perfusion
n  8). When the VF lasted
onger than 3 min, it was defi-
rillated by electrical shock. In a
eparate series of experiments,
he effect of ranolazine on H2O2
0.1 mM)-initiated VF was eval-
ated. This involved 2 protocols.
he purpose of the first protocol
as to determine the efficacy of
anolazine to suppress the VF
fter it is initiated in the contin-
ous presence of H2O2 (n  8).
he purpose of the second pro-
ocol was to test the efficacy of
anolazine to prevent the emer-
ence of VF when administered
0 min before H2O2 (0.1 mM,
 8).
-dimensional computer simu-
ation studies. Computer simu-
ations were performed in a
-dimensional (2D) tissue model with the membrane volt-
ge described by the following partial differential equation:
V
t
Iion ⁄CmD2Vx2  2Vy2 [1]
here Cm is the membrane capacitance set at 1F/cm
2,
ion is the total membrane ionic currents, and D is the
iffusion coefficient and was set as 0.0005 cm2/ms with
o-flux boundary conditions. Istim is the stimulation
urrent (a square pulse with a strength 40 F/cm2 and
uration of 1 ms). We used the ventricular myocyte
ction potential model that we developed recently (21).
he model was modified to generate EADs with detailed
hanges as described previously (7). To model the effects
f H2O2, in addition to increasing the maximum con-
uctance of ICaL by 2.6 and decreasing the maximum
onductance of the rapid delayed rectified potassium
urrent (IKr) by 20%, we also halved the rate of calcium
ptake by the sarcoplasmic reticulum and added INa-L
hat was equivalent to 0.1% of the peak INa amplitude (7).
he effects of ranolazine were simulated by decreasing
he late INa. We first paced a single myocyte with a square
ulse (Istim described above) to the steady-state and used
t as the initial condition for the myocytes in the whole
issue to save computer time. The 2D tissue then was
aced from the corner with 1 beat to allow EAD-
ediated focal VF to develop. After 1 min, the dynamics
f the focal VF-like state were analyzed in the presence
nd absence of INa-L to study ranolazine effect. Numer-
cally, Equation 1 was discretized with x  y  0.015
m and was integrated with a forward Euler method with
Abbreviations
and Acronyms
2D  2-dimensional
APD  action potential
duration
Cai
2  intracellular
calcium ion transient
dV/Dtmax  maximum rate
of phase-zero action
potential depolarization
EAD  early
afterdepolarization
H2O2  hydrogen peroxide
INa-L  late component of
the fast sodium inward
current
LV  left ventricle
VF  ventricular fibrillation
VT  ventricular
tachycardian adaptive time step varying from 0.01 to 0.1 ms.
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Late Sodium Current and Fibrillation January 18, 2011:366–75tatistical analyses. Significant differences in the incidence
f VF (dichotomous comparisons) were determined using
he Fisher exact test or McNemar test whenever appropri-
te. A likelihood ratio test was used to determine the
ignificance of site-specific origination of focal activity in
he LV. Rate-dependent changes in the Cai
2 decline rate
onstant (monoexponential fit), APD, resting potential,
aximum rate of phase-zero action potential depolarization
dV/Dtmax), and maximum slope of APD restitution curves
ere determined using 1-way repeated measures analyses of
ariance (ANOVA). Our 2-way repeated measures
NOVA between groups indicated linear trends between
roups and did not show interaction effect. Differences
mong individual means were verified subsequently by
ewman-Keuls post hoc tests. p  0.05 was considered
ignificant. All data are presented as mean  SD.
esults
acing-induced VF. When VF was induced by rapid
acing (Fig. 1A), activation mapping revealed 2 to 4
Figure 1 Activation During Pacing-Induced Ventricular Fibrillati
Snapshots of activation during pacing-induced ventricular fibrillation (A) at baseline an
wavefronts appear to maintain the induced ventricular fibrillation (Online Video 1), requ
ventricular fibrillation could still be induced, it self-terminated. D is a schematic drawin
shows snap shots taken just prior to termination of the ventricular fibrillation after ran
ization; ECG  electrocardiogram; F  fluorescence; F bar  mean fluorescence; MElec  mrregularly wandering wavelets that propagated freely over a
elatively large area on the epicardium, often colliding with
ther wavefronts (Fig. 1B) and initiating transient re-entry
Online Video 1). VF persisted (for 3 min) unless elec-
rically cardioverted (Fig. 1A). The activation patterns were
omparable with those previously reported in pacing-
nduced multiple wavelet VF in isolated swine (22), canine
23), and human ventricles (24). The effects of ranolazine on
he dynamics of pacing-induced VF were examined in 8
earts. Ranolazine did not prevent the induction of VF by
apid pacing (7 of 8 at baseline vs. 6 of 8 after ranolazine,
 NS) (Fig. 1C). However, after ranolazine, VF termi-
ated spontaneously in all 6 hearts after a mean of 12  6 s
Fig. 1C). Activation maps showed that ranolazine caused
rogressive reduction in the number of wavelets until only a
ingle wavefront remained, followed by quiescence and
esumption of sinus rhythm (Fig. 1E). Ranolazine signifi-
antly reduced the maximum slope of epicardial APD
estitution curve, from 1.3  0.5 to 0.85  0.3 (18 sites in
hearts) (p  0.05).
fter ranolazine (10 M) perfusion. (A) Multiple (2 to 4) propagating and colliding
lectrical shock for termination. (B) However, after ranolazine perfusion and while the
tical action potential showing the different phases of the action potential in color. E
as indicated by the double-headed arrow in C. SR is sinus rhythm. Dep  depolar-on
d (B) a
iring e
g of op
olazineicroelectrode; Rep  repolarization; SR  sinus rhythm.
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January 18, 2011:366–75 Late Sodium Current and Fibrillationnitiation and maintenance of VF by H2O2-mediated
ADs and triggered activity. INITIATION. Figure 2A il-
ustrates the onset of VF in a heart exposed to 0.1 mM
2O2. Focal VT arose suddenly during normal sinus
hythm (mean CL of 395  182 ms), and within 1 s
egenerated to VF. The mean CL of VT was 78  20 ms
nd that of VF was 60  18 ms (n  8). Focal VT arose
referentially (66%; p 0.05, likelihood ratio test) from the
ase of the LV epicardium (Fig. 2B) in 12 of 18 episodes in
hearts, consistent with our previous study (6). In the
emaining 6 episodes (34%), VT originated from the outside
f the mapped region and swept across a mapped region
rom either the apex (4 episodes) or the left lateral LV (2
pisodes) as a single wavefront. VF was sustained until
ardioverted electrically. To obtain insight into the mecha-
ism of VT preceding VF, after cardioversion of a VF
pisode, continuous action potential recordings were made
ith a roving glass microelectrode from the base of the LV
Figure 2 Initiation of VF in an Aged Rat Heart Exposed to H2O2
(A) Simultaneous optical action potential (O-AP), calcium transient (O-Cai) pseudo-
tion (EAD)-mediated ventricular tachycardia (VT)/ventricular fibrillation (VF). (B) Sna
arose from the base of the LV. The arrows point to the direction of wave propagat
arbitrarily set at 0. The color code is shown in C. (D) Glass microelectrode recordi
EAD-mediated triggered activity causing the VT. Note the isoelectric interval during
heart. (E) Multifocal activation during an episode of VF in the same heart (Online Vefore the next episode of spontaneous VT or VF. The LV sase was selected because of frequent origination of the focal
T (p  0.05) from this site. Figure 2D shows the onset of
spontaneous VT episode initiated by an EAD-mediated
riggered activity that causes focal VT, which then degen-
rated to VF, consistent with our previous study (6). The
AD-mediated triggered activity coincided in time with the
soelectric interval of the simultaneously recorded pseudo-
lectrocardiography (Fig. 2D), suggesting the absence of
lectrical activity elsewhere in the LV during the emergence
f the EAD. Furthermore the U-shaped smooth depolar-
zation of the EAD preceding the QRS complex of the VT
y a mean of 7  3 ms further suggested that the triggered
ctivity caused the VT.
AINTENANCE. We mapped wavefront activation patterns
etween 2 to 30 s after the onset of VF. Wavefront
ctivation patterns differed dramatically from those during
acing-induced VF in the same hearts before H2O2. As
mM) by an EAD-Mediated Triggered Activity
nd left atrial bipolar electrograms (LA Beg) at the onset of early afterdepolariza-
s during the last sinus beat (SR) and the first EAD-mediated triggered beat that
d the numbers under each snapshot are the activation time (ms) with onset time
the base of the heart in the same heart at the onset of another episode of
itiation of EAD indicating the absence of electrical activity elsewhere in the
). Abbreviations as in Figure 1.(0.1
ECG, a
pshot
ion an
ng from
the in
ideo 2hown in Figure 2E, VF was maintained by multiple
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Late Sodium Current and Fibrillation January 18, 2011:366–75picardial foci, appearing at a mean rate of 6.8  3.2 new
oci every 100 ms. These foci were caused by EAD-
ediated triggered activity that arose from a mean mem-
rane potential of 51  8 mV. Unlike the multiple wan-
ering wavelets VF (Fig. 1B), the multiple foci did not
ropagate freely across the epicardial surface. Instead, they
ypically remained confined to relatively small islands on the
picardium, with an average surface area of 2.8  0.85 mm2
Online Video 2). From a total of 1,945 epicardial foci
nalyzed in 6 hearts, the lifespan of a focus, from appearance to
xtinction, averaged 43 16 ms (Fig. 2E). In 92% of the cases,
xtinction occurred because the depolarization failed to spread
nto adjacent, more repolarized, tissue. In only 8% of the cases,
xtinction of the foci was the result of collisions with other foci
rising from adjoining sites 2 mm away.
ffects of ranolazine on H2O2-mediated multifocal
F. Ranolazine (10 M) perfusion, beginning 5 s after the
nset of H2O2-induced VF, terminated VF after a mean of
.1  0.4 min in 8 hearts (26 episodes) (Figs. 3A and 3B).
o subsequent EADs or triggered activity emerged during
anolazine perfusion for up to 1 h. On washout of ranola-
ine, EADs and triggered beats progressively reemerged in
of 8 hearts, culminating in spontaneous VF after a mean
ashout period of 36  10 min (Fig. 3B). In 8 additional
earts, ranolazine (10 M) was perfused for 30 min before
2O2. Ranolazine prevented VF in all 8 hearts for up to 1 h
f H2O2 exposure (Fig. 3C) (p  0.01, compared with
2O2 with no ranolazine). On washout of ranolazine in the
ontinued presence of H2O2, however, EADs progressively
merged in 7 of 8 hearts after a mean washout period of
5  8 min leading to VF (Fig. 3D).
To gain insight into the mechanism of VF termination by
anolazine, we analyzed epicardial activation maps. As
hown in Figures 4B and 4C, within 1 min, ranolazine
aused a significant (p  0.05) reduction in the number of
picardial foci, from 6.8  3.2 foci to 3.5  1.2 foci.
ventually, only a single focus remained, resulting in a brief
approximately 1 s) period of VT before the resumption of
inus rhythm (Fig. 4B).
ther electrophysiological effects of ranolazine. Ranola-
ine had no significant effect on the resting membrane poten-
ial (measured with an intracellular microelectrode) or action
otential duration to 50% and 90% repolarization, either before
r after H2O2 (35  7 ms vs. 32  4 ms and 106  5 ms vs.
02  8 ms, respectively; pacing cycle length  250 ms).
anolazine also had no effect on the ventricular effective
efractory period determined at a pacing cycle length of 250 ms
94  10 ms vs. 97  14 ms). However, ranolazine did cause
ignificant rate-dependent reduction of dV/Dtmax when the
acing CL was reduced from 250 to 130 and 100 ms, both at
aseline and after H2O2 consistent with ranolazine’s use-
ependent block of the Na current (9,25) (Fig. 5A). Ranola-
ine had no significant effect on conduction velocity measured
rom the LV epicardial base to the LV apex at pacing cycle
engths longer than 250 ms (54  8 cm/s vs. 56  10 cm/s).owever, at pacing cycle lengths of 250 ms and shorter, danolazine caused a slight but significant rate-dependent de-
rease in conduction velocity, as shown in Figure 5B, consis-
ent with its rate-dependent depressant of the fast INa reflected
s reduction in dV/Dtmax. Ranolazine had no significant effect
n the Cai
2 transient decline rate either before or after H2O2
Fig. 5C), consistent with a previous study in rat hearts
howing a minimal effect of ranolazine on the Cai
2 transient
uration (26). However, H2O2 caused significant slowing of
he rate constant of Cai
2 decline (84 6 ms vs. 108 10 ms,
 0.05) (Fig. 5B), but had no significant effect on the
aximum slope of the APD90 restitution curve (1.3  0.5 vs.
.2  0.5), consistent with our previous report (6).
D simulation of multifocal VF and the effect of ranolazine
n VF maintenance. Based on the experimental findings
escribed, we hypothesized that ranolazine suppressed mul-
ifocal VF by reducing the number of triggered foci below a
ritical number required to maintain VF. To test this
ypothesis, we simulated 2D cardiac tissue exhibiting mul-
ifocal VF, using a realistic cardiac action potential model
21) modified to generate EADs by mimicking the effects of
2O2 on INa-L and other currents (27). INa-L then was
locked to simulate the effects of ranolazine. As shown in
igures 6A and 6C, the number of foci progressively
ecreased, such that wavefronts emanating from the foci
pread over progressively wider regions, eventually leaving a
ingle wavefront causing transient VT before the tissue
ecame quiescent (Fig. 6A), in agreement with the experi-
ental findings.
iscussion
he major conclusion of this study is that the late Na
urrent blocking drug ranolazine demonstrates efficacy
gainst both pacing-induced re-entrant VF and spontane-
us oxidative multifocal VF. The suppression of multifocal
F by ranolazine is associated with a progressive reduction
n the number of foci. This finding supports the hypothesis
hat multifocal VF requires the constant generation of new
nteracting foci to maintain themselves such that when the
ate of production of new foci falls below a critical level, VF
erminates. This is analogous to re-entrant VF, in which a
ritical mass is required to ensure that the rate of formation
f new wavelets exceeds the rate of wavelet extinction (22).
ffects of ranolazine of pacing-induced re-entrant VF.
he suppressant effect of ranolazine against re-entrant VF is
ompatible with previous studies demonstrating the drug’s
fficacy to reducing dispersion of repolarization (28) and
ncreasing the VF threshold (14). In addition, we found that
anolazine significantly reduced the maximum slope of
PD restitution, which potentially contributes to its anti-
brillatory effect by preventing APD restitution-driven
avebreak (29). Although the main target of ranolazine is
he late Na current, other nonselective effects on IKr, IKs,
nd, to a lesser extent, ICaL (27) also are likely to be
mportant in its overall antiarrhythmic effects. Ranolazine
id not affect the Cai
2 decline rate and did not reverse
371JACC Vol. 57, No. 3, 2011 Morita et al.
January 18, 2011:366–75 Late Sodium Current and FibrillationFigure 3 Suppression and Prevention of EAD-Mediated Triggered Activity and VF by Ranolazine in Hearts Exposed to 0.1 mM H2O2
In all parts, the top recordings are pseudo-ECG and the bottom panels are glass microelectrode recordings. (A) Within 8 min of H2O2 perfusion, EADs emerge that then
progressively degenerate to triggered beats, causing VT and VF 15 min after H2O2. (B) Thirteen min after ranolazine (10 M) perfusion and in the continued presence of
H2O2, the VF remains suppressed for the entire 40 min of ranolazine perfusion. However, after ranolazine washout and in the continued presence of H2O2, EADs
emerged progressively, causing triggered beats and VF 65 min after washout of the drug. (C) Pre-treatment with ranolazine (10 M) for 30 min before H2O2 perfusion in
a different heart, preventing the formation of EADs and VF during the entire 60 min of ranolazine perfusion. However, on 40 min of ranolazine washout and in the contin-
ued presence of H O , the EADs emerged progressively, causing VT/VF 40 min after ranolazine washout as shown in D. Abbreviations as in Figures 1 and 2.2 2
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Late Sodium Current and Fibrillation January 18, 2011:366–752O2-mediated slowing of the Cai
2 decline rate, consis-
ent with a recent study showing a minimal effect of
anolazine on Cai
2 transient duration (26). However,
onsistent with previous studies (9,25) ranolazine caused a
ate-dependent decrease in dV/Dtmax and conduction ve-
ocity, particularly at faster rates of activation.
ffects of ranolazine of spontaneous multifocal VF. Pre-
ious studies of isolated myocytes have shown that ranola-
Figure 4 Spontaneous VF 15 s After Its Onset and Its Terminat
(A) Snapshots of spontaneous VF 15 s after its onset in a heart exposed to 0.1 m
of H2O2. Multiple epicardial foci (red) during the VF separated by recovered tissue
periodic optical mapping of the VF. However, 1 min after ranolazine perfusion (B),
and resumption of SR. (C) Time course of the reduction in the number of foci afteine has a potent suppressant effect on H2O2-mediated oADs and triggered activity (8). The present study extends
hese observations to EAD-mediated multifocal VF in
ntact hearts. Ranolazine progressively reduced the number
AD-mediated triggered foci, eventually terminating the
ultifocal VF. These findings suggest that the presence of
critical number of foci is necessary to maintain a multifocal
F, the rational being that EADs and triggered activity are
fterpotentials, and therefore their formation is dependent
ith Ranolazine in a Heart Exposed to 0.1 mM H2O2
O2 and (B) its termination with ranolazine (10 M) in the continuous presence
) is evident. This pattern of VF persisted for more than 3 min as confirmed by
mber of multiple foci progressively decreased, hastening the termination of VF
lazine perfusion. Abbreviations as in Figures 1 and 2.ion W
M H2
(blue
the nu
r ranon an obligatory prior excitation. This indicates that if no
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January 18, 2011:366–75 Late Sodium Current and Fibrillationew foci seem to generate new foci, the VF can not be
ustained, resulting in termination. The results of our 2D
imulation corroborate this experimental dynamic scenario
f multifocal VF termination. Reduction in the number of
oci caused by the suppression of the late INa led to a
rogressive reduction of the number of foci resulting in VF
ermination. The role of wavebreak in the maintenance of
2O2-mediated VF seems to be minimal, because the foci
emained confined to small regions (2 to 3 mm2) on the
picardium, with wavefront–wavefront collisions observed
n only 4% of cases. There are several possible reasons why
he foci remained spatially confined. The spread of foci may
ave been mediated by phase waves resulting from synchro-
ization of EAD oscillations (7), rather than true propaga-
ion. Alternatively, outward propagation from the center of
oci may have been decremental as a result of refractoriness
f surrounding tissue. After ranolazine reduced the number
f foci, regenerative outward propagation from foci was
bserved more frequently, consistent with the surrounding
Figure 5 Effects of Ranolazine on Maximum Rate of Phase-Zer
(dV/Dtmax) of Phase Zero Action Potential, Conductio
(A) Ranolazine causing rate-dependent significant decrease in dV/Dtmax at faster p
code (right) during pacing from the base at a PCL of 200 ms under different cond
before or after H2O2, as shown by the adjoining superimposed Cai
2 transients.issue having had more time to recover excitability. mtudy limitations. In surface epicardial maps, an intramu-
al wavefront breaking through the surface may have the
ppearance of a focus. However, we previously demon-
trated that after endocardial and midmyocardial ablation,
he epicardial cells have an intrinsic ability to generate H2O2-
nduced EADs, triggered activity, and VF (6). However, we
an not dismiss the potential role of the endocardial Purkinje
ber network in the initiation and maintenance of focal VF
30,31). It could be argued that the observed epicardial focal
echanism may result from micro–re-entry, rather than trig-
ered foci (32). Our single-cell microelectrode recordings from
picardial focal sites showing cellular EAD-mediated triggered
ctivity and our 2D simulation showing EAD-mediated mul-
ifocal VF provide further suggestive evidence for a focal
riggered activity, rather than a micro–re-entrant mechanism
or VF. Although H2O2 is an artificial means of inducing
xidative stress, the 0.1-mM concentration used in this study is
onsidered relevant to pathophysiological levels under condi-
ions such as ischemia–reperfusion (33–35). Furthermore, it
ion Potential Depolarization
locity, and Cai
2 Transient Decline Rate Constant ()
cycle length (PCL) (130 ms). (B, left) Isochronal activation maps with a color
(C) H2O2 prolongs , whereas ranolazine (10 M) has no effect on  eithero Act
n Ve
acing
itions.ust be emphasized that the efficacy of ranolazine needs to be
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road antifibrillatory efficacy. Finally, ranolazine’s IKr-blocking
nfluence, which conceivably could account for its demon-
trated ability to decrease ventricular defibrillation threshold
14) and perhaps re-entrant VF as well, was not tested in our
omputer model.
onclusions
o our knowledge, this is the first study to demonstrate that
anolazine has a potent suppressant effect on both re-entrant
nd multifocal VF at concentrations considered therapeutic in
umans (36,37). Our findings support previous studies dem-
nstrating ranolazine’s efficacy against H2O2-mediated EADs
nd triggered activity in isolated cardiac myocytes (8,15), in
solated tissue (10), as well as ventricular arrhythmias in animal
odels (14,28,38) and in humans (39). Although H2O2 is an
rtificial means of inducing oxidative stress, there are many
nown triggers of oxidative stress in the heart, such as aging
40), heart failure (41), and ischemia–reperfusion (35), which
re all conditions associated with increased risk of VF. The
ffect of ranolazine to reduce reperfusion arrhythmias signifi-
antly (42) indicates that the drug could exert a potent
ntiarrhythmic effect under conditions of oxidative stress (33).
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